Yüklüyor......
dUTPase inhibition augments replication defects of 5-Fluorouracil
The antimetabolite 5-Fluorouracil (5-FU) is used in the treatment of various forms of cancer and has a complex mode of action. Despite 6 decades in clinical application the contribution of 5-FdUTP and dUTP [(5-F)dUTP] and 5-FUTP misincorporation into DNA and RNA respectively, for 5-FU-induced toxici...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410339/ https://ncbi.nlm.nih.gov/pubmed/28423595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15785 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|